Futuro del CRPC. Visión 360º

Previous Page

Next Page

Page Background

GETUG-AFU 15 subsequent treatments for mCRPC

Docetaxel for mCRPC after ADT alone for mHSPC

45%

Docetaxel for mCRPC after ADT+ docetaxel for mHSPC

14%

Abi/Enza for mCRPC after ADT+ docetaxel for mHSPC

53%